Sudeep Pharma Share Price Analyzed
Key Points
- Sudeep Pharma shares fell, impacting investor confidence this week.
- Weak September quarter results triggered the price decline.
- Lower profits compared to the previous year caused concern.
- Revenue increased, but profit margins narrowed significantly.
- USFDA-certified facilities ensure high-quality product delivery.
- The company’s history shows a strong global presence.
On Monday, December 22, 2025, the stock price of Sudeep Pharma experienced a noticeable drop. The shares decreased by as much as 6.03% to reach a low of ₹644.90 per share. At 9:25 AM, the stock was trading at ₹658.90, still down 4% compared to the previous close.
This decrease happened while the broader market, represented by the BSE Sensex, was moving upwards. The Sensex was up 0.53% at 85,382.23 levels. This highlights that Sudeep Pharma’s performance is independent of the overall market trend.
The primary reason for this fall was the company’s reported financial results for the September quarter of financial year 2026 (Q2FY26). Their profit decreased by 4% compared to the same quarter last year, dropping to ₹46.8 crore. This was a change from ₹48.7 crore reported in Q2FY25.
Despite the profit decline, the company’s revenue increased to ₹162.7 crore – up from ₹148.8 crore in the previous year. However, the earnings before interest, tax, depreciation and amortisation (Ebitda) remained almost the same at ₹65.6 crore.
A key factor driving the price drop was a significant reduction in the Ebitda margin. This went from 43.4% to just 38% during the same period. This decrease affected their earnings per share, which fell to ₹4.20 compared to ₹4.49 previously.
Sudeep Pharma was established in 1989. They are known for producing mineral-based excipients, specialty nutrition ingredients, and food-grade minerals. Their products are used in pharmaceuticals, nutrition, and food industries, and they sell them to over 100 countries through facilities that meet USFDA standards.
“Understanding Sudeep Pharma’s financial performance is crucial for assessing its long-term value and investment potential.”
